 id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baechler</surname><given-names>EC</given-names></name><name><surname>Gregersen</surname><given-names>PK</given-names></name><name><surname>Behrens</surname><given-names>TW</given-names></name></person-group><article-title>The emerging role of interferon in human systemic lupus erythematosus</article-title><source>Curr Opin Immunol</source><year>2004</year><volume>16</volume><fpage>801</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2004.09.014</pub-id><pub-id pub-id-type="pmid">15511676</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirou</surname><given-names>KA</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Louca</surname><given-names>K</given-names></name><name><surname>Papagiannis</surname><given-names>IG</given-names></name><name><surname>Peterson</surname><given-names>MGE</given-names></name><etal/></person-group><article-title>Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>2004</year><volume>50</volume><fpage>3958</fpage><lpage>3967</lpage><pub-id pub-id-type="doi">10.1002/art.20798</pub-id><pub-id pub-id-type="pmid">15593221</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baechler</surname><given-names>EC</given-names></name><name><surname>Batliwalla</surname><given-names>FM</given-names></name><name><surname>Karypis</surname><given-names>G</given-names></name><name><surname>Gaffney</surname><given-names>PM</given-names></name><name><surname>Ortmann</surname><given-names>WA</given-names></name><name><surname>Espe</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>2610</fpage><lpage>2615</lpage><pub-id pub-id-type="doi">10.1073/pnas.0337679100</pub-id><pub-id pub-id-type="pmid">12604793</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>CE</given-names></name><name><surname>Gavin</surname><given-names>AL</given-names></name><name><surname>Migone</surname><given-names>T-S</given-names></name><name><surname>Hilbert</surname><given-names>DM</given-names></name><name><surname>Nemazee</surname><given-names>D</given-names></name><name><surname>Stohl</surname><given-names>W</given-names></name></person-group><article-title>B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels</article-title><source>Arthritis Res Ther</source><year>2006</year><volume>8</volume><fpage>R6</fpage><pub-id pub-id-type="doi">10.1186/ar1855</pub-id><pub-id pub-id-type="pmid">16356193</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayson</surname><given-names>PC</given-names></name><name><surname>Carmona-Rivera</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Lim</surname><given-names>N</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Asare</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in Antineutrophil cytoplasmic antibody-associated Vasculitis</article-title><source>Arthritis Rheumatol</source><year>2015</year><volume>67</volume><fpage>1922</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.1002/art.39153</pub-id><pub-id pub-id-type="pmid">25891759</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katewa</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hackney</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Suto</surname><given-names>E</given-names></name><name><surname>Ramamoorthi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell&#x02013;associated damage in IFN&#x003b1;-driven lupus nephritis</article-title><source>JCI Insight</source><year>2017</year><volume>2</volume><fpage>e90111</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.90111</pub-id><?supplied-pmid 28405610?><pub-id pub-id-type="pmid">28405610</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermoser</surname><given-names>G</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name></person-group><article-title>The interferon-alpha signature of systemic lupus erythematosus</article-title><source>Lupus</source><year>2010</year><volume>19</volume><fpage>1012</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1177/0961203310371161</pub-id><pub-id pub-id-type="pmid">20693194</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkon</surname><given-names>KB</given-names></name><name><surname>Wiedeman</surname><given-names>A</given-names></name></person-group><article-title>Type I IFN system in the development and manifestations of SLE</article-title><source>Curr Opin Rheumatol</source><year>2012</year><volume>24</volume><fpage>499</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1097/BOR.0b013e3283562c3e</pub-id><pub-id pub-id-type="pmid">22832823</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landolt-Marticorena</surname><given-names>C</given-names></name><name><surname>Bonventi</surname><given-names>G</given-names></name><name><surname>Lubovich</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>C</given-names></name><name><surname>Unnithan</surname><given-names>T</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><etal/></person-group><article-title>Lack of association between the interferon-&#x003b1; signature and longitudinal changes in disease activity in systemic lupus erythematosus</article-title><source>Ann Rheum Dis</source><year>2009</year><volume>68</volume><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="doi">10.1136/ard.2008.093146</pub-id><pub-id pub-id-type="pmid">18772188</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Tesfasyone</surname><given-names>H</given-names></name><name><surname>Dedrick</surname><given-names>R</given-names></name><name><surname>Fry</surname><given-names>K</given-names></name><name><surname>Lal</surname><given-names>P</given-names></name><etal/></person-group><article-title>Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus</article-title><source>Lupus</source><year>2009</year><volume>18</volume><fpage>980</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1177/0961203309105529</pub-id><pub-id pub-id-type="pmid">19762399</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiche</surname><given-names>L</given-names></name><name><surname>Jourde-Chiche</surname><given-names>N</given-names></name><name><surname>Whalen</surname><given-names>E</given-names></name><name><surname>Presnell</surname><given-names>S</given-names></name><name><surname>Gersuk</surname><given-names>V</given-names></name><name><surname>Dang</surname><given-names>K</given-names></name><etal/></person-group><article-title>Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures</article-title><source>Arthritis Rheumatol (Hoboken, NJ)</source><year>2014</year><volume>66</volume><fpage>1583</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1002/art.38628</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>F</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name></person-group><article-title>Cracking the BAFF code</article-title><source>Nat Rev Immunol</source><year>2009</year><volume>9</volume><fpage>491</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/nri2572</pub-id><pub-id pub-id-type="pmid">19521398</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheema</surname><given-names>GS</given-names></name><name><surname>Roschke</surname><given-names>V</given-names></name><name><surname>Hilbert</surname><given-names>DM</given-names></name><name><surname>Stohl</surname><given-names>W</given-names></name></person-group><article-title>Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases</article-title><source>Arthritis Rheum</source><year>2001</year><volume>44</volume><fpage>1313</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1002/1529-0131(200106)44:6&#x0003c;1313::AID-ART223&#x0003e;3.0.CO;2-S</pub-id><pub-id pub-id-type="pmid">11407690</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker-Merok</surname><given-names>a</given-names></name><name><surname>Nikolaisen</surname><given-names>C</given-names></name><name><surname>Nossent</surname><given-names>HC</given-names></name></person-group><article-title>B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time</article-title><source>Lupus</source><year>2006</year><volume>15</volume><fpage>570</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1177/0961203306071871</pub-id><pub-id pub-id-type="pmid">17080911</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stohl</surname><given-names>W</given-names></name><name><surname>Metyas</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>SM</given-names></name><name><surname>Cheema</surname><given-names>GS</given-names></name><name><surname>Oamar</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><etal/></person-group><article-title>B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations</article-title><source>Arthritis Rheum</source><year>2003</year><volume>48</volume><fpage>3475</fpage><lpage>3486</lpage><pub-id pub-id-type="doi">10.1002/art.11354</pub-id><pub-id pub-id-type="pmid">14673998</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zollars</surname><given-names>E</given-names></name><name><surname>Bienkowska</surname><given-names>J</given-names></name><name><surname>Czerkowicz</surname><given-names>J</given-names></name><name><surname>Allaire</surname><given-names>N</given-names></name><name><surname>Ranger</surname><given-names>AM</given-names></name><name><surname>Magder</surname><given-names>L</given-names></name><etal/></person-group><article-title>BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year</article-title><source>Lupus Sci Med</source><year>2015</year><volume>2</volume><fpage>e000063</fpage><pub-id pub-id-type="doi">10.1136/lupus-2014-000063</pub-id><pub-id pub-id-type="pmid">26113988</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denny</surname><given-names>MF</given-names></name><name><surname>Yalavarthi</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Thacker</surname><given-names>SG</given-names></name><name><surname>Anderson</surname><given-names>M</given-names></name><name><surname>Sandy</surname><given-names>AR</given-names></name><etal/></person-group><article-title>A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><fpage>3284</fpage><lpage>3297</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902199</pub-id><pub-id pub-id-type="pmid">20164424</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakkim</surname><given-names>A</given-names></name><name><surname>F&#x000fc;rnrohr</surname><given-names>BG</given-names></name><name><surname>Amann</surname><given-names>K</given-names></name><name><surname>Laube</surname><given-names>B</given-names></name><name><surname>Abed</surname><given-names>UA</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><etal/></person-group><article-title>Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>9813</fpage><lpage>9818</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909927107</pub-id><pub-id pub-id-type="pmid">20439745</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>MJ</given-names></name></person-group><article-title>Neutrophils in the pathogenesis and manifestations of SLE</article-title><source>Nat Rev Rheumatol</source><year>2011</year><volume>7</volume><fpage>691</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2011.132</pub-id><pub-id pub-id-type="pmid">21947176</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>L</given-names></name><name><surname>Palucka</surname><given-names>AK</given-names></name><name><surname>Arce</surname><given-names>E</given-names></name><name><surname>Cantrell</surname><given-names>V</given-names></name><name><surname>Borvak</surname><given-names>J</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><etal/></person-group><article-title>Interferon and Granulopoiesis signatures in systemic lupus erythematosus blood</article-title><source>J Exp Med</source><year>2003</year><volume>197</volume><fpage>711</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1084/jem.20021553</pub-id><pub-id pub-id-type="pmid">12642603</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villanueva</surname><given-names>E</given-names></name><name><surname>Yalavarthi</surname><given-names>S</given-names></name><name><surname>Berthier</surname><given-names>CC</given-names></name><name><surname>Hodgin</surname><given-names>JB</given-names></name><name><surname>Khandpur</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Netting neutrophils induce endothelial damage, infiltrate tissues, and expose Immunostimulatory molecules in systemic lupus erythematosus</article-title><source>J Immunol</source><year>2011</year><volume>187</volume><fpage>538</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100450</pub-id><pub-id pub-id-type="pmid">21613614</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Jourde-Chiche N, Whalen E, Gondouin B, Speake C, Gersuk V, Dussol B, et al. Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis. Rheumatology. 2016;56:477&#x02013;87.</mixed-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streicher</surname><given-names>K</given-names></name><name><surname>Morehouse</surname><given-names>CA</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Rajan</surname><given-names>B</given-names></name><name><surname>Pilataxi</surname><given-names>F</given-names></name><name><surname>Lehmann</surname><given-names>KP</given-names></name><etal/></person-group><article-title>The plasma cell signature in autoimmune disease</article-title><source>Arthritis Rheumatol (Hoboken, NJ)</source><year>2014</year><volume>66</volume><fpage>173</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1002/art.38194</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Akhter</surname><given-names>E</given-names></name><name><surname>Bienkowska</surname><given-names>J</given-names></name></person-group><article-title>Association between plasma cell gene signature and disease characteristics in systemic lupus erythematosus [abstract]</article-title><source>Arthritis Rheum</source><year>2011</year><volume>63</volume><issue>Suppl 10</issue><fpage>1920</fpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>EM</given-names></name><name><surname>Cohen</surname><given-names>AS</given-names></name><name><surname>Fries</surname><given-names>JF</given-names></name><name><surname>Masi</surname><given-names>AT</given-names></name><name><surname>Mcshane</surname><given-names>DJ</given-names></name><name><surname>Rothfield</surname><given-names>NF</given-names></name><etal/></person-group><article-title>The 1982 revised criteria for the classification of systemic lupus erythrematosus</article-title><source>Arthritis Rheum</source><year>1982</year><volume>25</volume><fpage>1271</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1002/art.1780251101</pub-id><pub-id pub-id-type="pmid">7138600</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochberg</surname><given-names>MC</given-names></name></person-group><article-title>Updating the American College of Rheumatology Revised criteria for the classification of systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>1997</year><volume>40</volume><fpage>1725</fpage><pub-id pub-id-type="doi">10.1002/art.1780400928</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Orbai</surname><given-names>A-M</given-names></name><name><surname>Alarc&#x000f3;n</surname><given-names>GS</given-names></name><name><surname>Gordon</surname><given-names>C</given-names></name><name><surname>Merrill</surname><given-names>JT</given-names></name><name><surname>Fortin</surname><given-names>PR</given-names></name><etal/></person-group><article-title>Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>2012</year><volume>64</volume><fpage>2677</fpage><lpage>2686</lpage><pub-id pub-id-type="doi">10.1002/art.34473</pub-id><pub-id pub-id-type="pmid">22553077</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Kalunian</surname><given-names>KC</given-names></name><name><surname>Grossman</surname><given-names>J</given-names></name><name><surname>Hahn</surname><given-names>BH</given-names></name><name><surname>Sammaritano</surname><given-names>LR</given-names></name><etal/></person-group><article-title>Combined oral contraceptives in women with systemic lupus erythematosus</article-title><source>N Engl J Med</source><year>2005</year><volume>353</volume><fpage>2550</fpage><lpage>2558</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa051135</pub-id><pub-id pub-id-type="pmid">16354891</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bombardier</surname><given-names>C</given-names></name><name><surname>Gladman</surname><given-names>DD</given-names></name><name><surname>Urowitz</surname><given-names>MB</given-names></name><name><surname>Caron</surname><given-names>D</given-names></name><name><surname>Chang</surname><given-names>CH</given-names></name></person-group><article-title>Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE</article-title><source>Arthritis Rheum</source><year>1992</year><volume>35</volume><fpage>630</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1002/art.1780350606</pub-id><pub-id pub-id-type="pmid">1599520</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Hellmann</surname><given-names>D</given-names></name><name><surname>Hochberg</surname><given-names>M</given-names></name></person-group><article-title>Validity and reliability of lupus activity measures in the routine clinic setting</article-title><source>J Rheumatol</source><year>1992</year><volume>19</volume><fpage>53</fpage><lpage>59</lpage><?supplied-pmid 1556700?><pub-id pub-id-type="pmid">1556700</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuhaus</surname><given-names>JM</given-names></name><name><surname>Kalbfleisch</surname><given-names>JD</given-names></name></person-group><article-title>Between- and within-cluster covariate effects in the analysis of clustered data</article-title><source>Biometrics</source><year>1998</year><volume>54</volume><fpage>638</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.2307/3109770</pub-id><pub-id pub-id-type="pmid">9629647</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>LM</given-names></name><name><surname>Isenberg</surname><given-names>DA</given-names></name><name><surname>Ehrenstein</surname><given-names>MR</given-names></name></person-group><article-title>Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>2013</year><volume>65</volume><fpage>2672</fpage><lpage>2679</lpage><?supplied-pmid 23839909?><pub-id pub-id-type="pmid">23839909</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Midgley A, Beresford MW. Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. Lupus. 2016;25:407&#x02013;11.</mixed-citation></ref></